Skip to main content

Table 1 The clinicopathologic features of the patients studied

From: RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

Patient characteristics (n = 140)
Feature Frequency (n,%)
Gender
Male 66 (47.1)
Female 74 (52.9)
Age (years)
Mean (min, max) 74.3 (30–97)
Tumor size (mm)
Mean (min, max) 5.17 (1, 11)
Tumor grade
Low 25 (17.9)
High 115 (82.1%)
Lymphovascular invasion
Present 13 (9.3)
Not present 127 (90.7)
Recurrence
Yes 19 (13.7)
No 120 (86.3%)
Average follow-up time (mean, range)
76.6 months (16–250)
  1. All patients were diagnosed with Stage II colorectal adenocarcinoma. Samples were collected between the years of 1986 to 2005 from the archives of the Department of Pathology at the Rhode Island Hospital.